IDEXX Laboratories Inc (IDXX) bonds
IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$698.47+8.23 (+1.19%)
Close on Nov 18, 2026Market cap $55.03BP/E 49.1Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$449.86M
$150.00M due within a year
Net debt
$252.93M
After $196.93M of cash
Implied interest rate
7.28%
FY2025 interest ÷ average debt
Interest coverage
35.0×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in IDEXX Laboratories's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Matures | Amount issued |
|---|---|---|---|
| 2026 Senior Notes | 3.72% | 2026 | $75.00M |
| 2021 Series A Notes | 3.32% | – | $50.00M |
| 2021 Series A Notes and 2024 Series B Notes | – | – | $125.00M |
| 2022 Series A Notes | 3.25% | – | $75.00M |
| 2022 Series A Notes and 2027 Series B Notes | – | – | $150.00M |
| 2023 Series A Notes | 3.94% | – | $75.00M |
| 2023 Series A Notes and 2025 Series B Notes | – | – | $150.00M |
| 2024 Series B Notes | 3.76% | – | $75.00M |
| 2025 Series B Notes | 4.04% | – | $75.00M |
| 2025 Series C Notes | 1.79% | – | €88.90M |
| 2027 Series B Notes | 3.72% | – | $75.00M |
| 2029 Series C Notes | 4.19% | – | $100.00M |
| MetLife 2030 Series D Notes | 2.50% | – | $125.00M |
| Prudential 2030 Series D Notes | 2.50% | – | $75.00M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Available |
|---|---|---|
| Revolving Credit Facility | $1.25B | $729.20M |
| Revolving Credit Facility | – | – |
| Term Loan | $250.00M | – |
| Term Loan | – | – |
See a number that looks wrong?